PipelineReview Store - Biotech Reports by Datamomitor, Kalorama, La Merie, Life Science Analytics, Scientia Veritas - PipelineReview Store

Pharmaceutical Company Outlook to 2014	6,069 EUR [$7,600.00 USD]
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014	6,069 EUR [$7,600.00 USD]
Pipeline Insight: Biologic Targeted Cancer Therapies - Next generation jostles for market position	9,103 EUR [$11,400.00 USD]

New Products For May

Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study	3,713 EUR [$4,650.00 USD]
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019	3,190 EUR [$3,995.00 USD]
Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth	2,795 EUR [$3,500.00 USD]
Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation	2,795 EUR [$3,500.00 USD]
Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion	2,795 EUR [$3,500.00 USD]
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules	2,795 EUR [$3,500.00 USD]
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments	2,795 EUR [$3,500.00 USD]
Chronic Kidney Disease (CKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018	2,515 EUR [$3,150.00 USD]
Backup Compound Strategies: Commercial and Tactical Considerations	1,992 EUR [$2,495.00 USD]

Upcoming Products	Date Expected

Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Peptides	05/30/2012
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Protein Kinase Inhibitors	05/30/2012
Triple Analysis: Pancreatic Cancer, Apoptosis and Protein Kinase Inhibitors	05/30/2012
Triple Analysis: Pancreatic Cancer, Angiogenesis and Protein Kinase Inhibitors	05/30/2012
Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Protein Kinase Inhibitors	05/30/2012
Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Antibodies	05/30/2012
Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Peptides	05/30/2012
Triple Analysis: Prostate Cancer, Apoptosis and Angiogenesis	05/30/2012
Triple Analysis: Prostate Cancer, Angiogenesis and Cancer Vaccines	05/30/2012
Triple Analysis: Prostate Cancer, Angiogenesis and Protein Kinase Inhibitors	05/30/2012

Currencies

Shopping Cart

0 items

Quick Find



Any wordAll words Exact Phrase
Use keywords to find the product you are looking for. Advanced Search

Bestsellers

01.	Competitor Analysis: Erythropoietin (EPO)
02.	Competitor Analysis: Anti-Obesity Peptides and Biologics
03.	Competitor Analysis: IGF-1R Antagonists
04.	Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors
05.	Competitor Analysis: Coagulation Factors

Specials

Newest Product

PipelineReview.com is powered by La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

Secure Websites